Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDP (HELIPAD 1)
A Multicenter Pilot Study to Determine Criteria for Evaluating the Effectiveness of Two Comparative Monitoring Methods in the Management of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Receiving Home-based Treatment With IVIg (Privigen®)
Sponsor: CSL Behring
Terminated
Due to logistical concerns
Other terminated trials from CSL Behring
Other Chronic Inflammatory Demyelinating Polyneuropathy trials with similar outcome
Browse all Chronic Inflammatory Demyelinating Polyneuropathy trials
Listed as NCT03779828, this observational or N/A phase trial focuses on Chronic Inflammatory Demyelinating Polyneuropathy and remains terminated or withdrawn. Sponsored by CSL Behring, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Feb 2021 — Jul 2024 [monthly]
Terminated
Status: Completed → Terminated
-
Jan 2021 — Feb 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Jan 2019 — Feb 2020 [monthly]
Recruiting
First recorded
Nov 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CSL Behring
For direct contact, visit the study record on ClinicalTrials.gov .